Sepsis Diagnostics Market By Product (Instruments, Blood Culture Media, Assay Kits & Reagents and Software) By Technology (Microbiology, Molecular Diagnostics, Immunoassays, Biomarkers and Others) By Pathogen (Bacterial, Fungal and Others) By End Users (Pathology Laboratories, Hospitals, Research Laboratories & Academic Institutes and Others), and By Region - Trends, Analysis, and Forecast till 2029

Sepsis Diagnostics Market accounted for USD 530.5 Million in 2020 and is estimated to be USD 1070 Million by 2029 and is anticipated to register a CAGR of 8.1%.

Sepsis is a kind of severe life-threatening organ dysfunction that emerges due to the overwhelming response of the body to infection harming its own tissues and organs. Sepsis arises due to the body’s reaction to bacterial, fungal, parasitic, or viral infection, which may lead to multiple organ failure, septic shock, and death. According to W.H.O., sepsis kills 11 million people each year, many of them children. And the most common causes of sepsis-related deaths were diarrhoeal diseases, lower respiratory infections, and neonatal disorders among children. The high prevalence and increasing mortality rate due to sepsis are largely driving the demand for sepsis diagnostics products and solutions.

The high prevalence of sepsis and high incidence of hospital-acquired infections are expected to be the significant factor driving the sepsis diagnostics market across the globe. The government initiatives and funding for research activities are projected to boost the sepsis diagnostics market growth by the end of the forecast period.

The rising health awareness and healthcare expenditures among the people is anticipated to boost the sepsis diagnostics market growth in the forecast period. According to a W.H.O. report, 1 in 5 deaths is caused due to sepsis across the globe. The alarming fact and figures of various health organizations towards sepsis are likely to aware people of different regions. The aging population and health freaks are likely to demand sepsis diagnostics solutions which are expected to be the major factor driving the growth of the sepsis diagnostics market. Moreover, the major player of the sepsis diagnostics market has an opportunity to strengthen their presence in developing economies and acquiring considerable market share through partnerships with local players.

Restraints :

The knowledge gap and minimal government efforts in low and middle-income countries may hamper the growth of the sepsis diagnostics market. Also, limited skilled staff and lack of established health systems in developing countries are hindering the growth of the sepsis diagnostics market

Sepsis diagnostics market is segmented based on the product, technology, pathogen, end-users, and region.

On the basis of product type, the sepsis diagnostics market is segmented into instruments, blood culture media, assay kits, and reagents and software. On the basis of technology, the market is segmented in microbiology, molecular diagnostics, immunoassays, biomarkers, and others. On the basis of pathogens, the sepsis diagnostics market is segmented into bacterial, fungal, and others. On the basis of end-user, the target market is segmented into pathology laboratories, hospitals, research laboratories & academic institutes, and others.

Regional Insights:

In the region, the sepsis diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is well established in the sepsis diagnostics market, due to the presence of a developed healthcare system and technological advancements in the region. The high adoption rate for new sepsis diagnostics techniques among medical professionals is one of the factors driving the North American sepsis diagnostics market. Asia Pacific region is projected to grow with a high growth rate in the sepsis diagnostics market by the end of the forecast period.

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2020 to 2029.  For the purpose of this study, has segmented the sepsis diagnostics market report based on the product, technology, pathogen, end-users, and region.

Sepsis Diagnostics Market, By Product Type:

• Instruments
• Blood Culture Media
• Assay Kits and Reagents
• Software

Sepsis Diagnostics Market, By Technology Type:

• Microbiology
• Molecular Diagnostics
• Immunoassays
• Biomarkers
• Others

Sepsis Diagnostics Market, By Pathogen Type:

• Bacterial
• Fungal
• Others

Sepsis Diagnostics Market, By End Users Type:

• Pathology Laboratories
• Hospitals
• Research Laboratories & Academic Institutes
• Others

Sepsis Diagnostics Market, By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

The key players operating in the sepsis diagnostics market include Abbott Laboratories, Becton, Dickinson and Company, Cepheid Inc., Luminex Corporation, T2 Biosystems, Inc., Thermo Fisher Scientific, Inc., bioMérieux SA, Bruker Corporation, Roche Diagnostics Limited, and other players. The major player in the sepsis diagnostics market is focusing on the research and development of new products and adopting new growth strategies. The players involved in the sepsis diagnostics market investing deliberately to build their distribution channel to serve developing markets.  Some companies also adopting new technologies through merger acquisitions and partnerships to strengthen their product portfolio.  

• Abbott Laboratories
• Becton, Dickinson and Company,
• bioMérieux SA
• Bruker Corporation
• Cepheid Inc.
• EKF Diagnostics
• Luminex Corporation
• Roche Diagnostics Limited
• T2 Biosystems, Inc.
• Thermo Fisher Scientific, Inc.